Grifols offers a collection kit for customers. Please follow instructions inside the kit. To order your kit, please go to the Test Ordering section.
Grifols also accepts direct ordering from labs, physician offices or others. Please follow the instructions below for the correct preparation of the sample to ensure successful delivery.
TDMonitor Infliximab (IFX)
TDMonitor Infliximab (IFX)
| Test Code | 9008922 |
| Test Name | TDMonitor Infliximab (IFX) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of infliximab and free (unbound) anti-infliximab antibodies in human serum. |
| Detailed Description | The infliximab concentration is determined on a solid-phase capture EIA that makes use of TNFα and an infliximab-specific human monoclonal antibody. The concentration of anti-infliximab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of infliximab and the concentration of anti-infliximab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. The therapeutic range of infliximab has been reported at 3-7 μg/mL in inflammatory bowel disease. This range has been associated with fewer flares during the course of the treatment. |
Grifols offers a collection kit for customers. Please, follow instructions inside the kit. To order your kit, please visit Test Ordering > Collection Kits
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of infliximab trough levels is important when interpreting the concentration of anti-infliximab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before infliximab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of infliximab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before infliximab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of infliximab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
The U.S. Food and Drug Administration (FDA) has not approved this test. The results of this test are not intended to be used as the sole means of patient management decisions.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Adalimumab (ADL)
TDMonitor Adalimumab (ADL)
| Test Code | 9008923 |
| Test Name | TDMonitor Adalimumab (ADL) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of adalimumab and free (unbound) anti-adalimumab antibodies in human serum. |
| Detailed Description | The adalimumab concentration is determined on a solid-phase capture EIA that makes use of an adalimumab-specific human monoclonal antibody. The concentration of anti-adalimumab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of adalimumab and the concentration of anti-adalimumab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. Trough levels of adalimumab are higher in inflammatory bowel disease patients in clinical remission. Detection of antibodies to adalimumab predicts a lack of mucosal healing. The therapeutic range of adalimumab has been reported at 5-8 μg/mL in inflammatory bowel disease and rheumatoid arthritis. |
Grifols offers a collection kit for customers. Please, follow instructions inside the kit. To order your kit, please visit Test Ordering > Collection Kits
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of adalimumab trough levels is important when interpreting the concentration of anti-adalimumab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before adalimumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of adalimumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before adalimumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of adalimumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If serum is not analyzed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
The U.S. Food and Drug Administration (FDA) has not approved this test. The results of this test are not intended to be used as the sole means of patient management decisions.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Vedolizumab (VDL)
TDMonitor Vedolizumab (VDL)
| Test Code | 9008772 |
| Test Name | TDMonitor Vedolizumab (VDL) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of vedolizumab and free (unbound) anti-vedolizumab antibodies in human serum. |
| Detailed Description | The vedolizumab concentration is determined on a solid-phase capture EIA that makes use of an vedolizumab-specific human monoclonal antibody. The concentration of anti-vedolizumab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of vedolizumab and the concentration of anti-vedolizumab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a collection kit to customers. To order a kit, visit Test Ordering - Instructions. Please, follow instructions inside the kit.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of vedolizumab trough levels is important when interpreting the concentration of anti-vedolizumab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before vedolizumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of vedolizumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before vedolizumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of vedolizumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If serum is not analyzed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
The U.S. Food and Drug Administration (FDA) has not approved this test. The results of this test are not intended to be used as the sole means of patient management decisions.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Ustekinumab (UTK)
TDMonitor Ustekinumab (UTK)
| Test Code | 9008924 |
| Test Name | TDMonitor Ustekinumab (UTK) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of ustekinumab and free (unbound) anti-ustekinumab antibodies in human serum. |
| Detailed Description | The ustekinumab concentration is determined on a solid-phase capture EIA that makes use of an ustekinumab-specific human monoclonal antibody. The concentration of anti-ustekinumab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of ustekinumab and the concentration of anti-ustekinumab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a collection kit to customers. To order a kit, visit Test Ordering - Instructions. Please, follow instructions inside the kit.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of ustekinumab trough levels is important when interpreting the concentration of anti-ustekinumab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before ustekinumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of ustekinumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before ustekinumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of ustekinumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If not be processed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
For Research Use Only (RUO). Not for use in diagnostic procedures.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Golimumab (GLM)
TDMonitor Golimumab (GLM)
| Test Code | 9008925 |
| Test Name | TDMonitor Golimumab (GLM) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of golimumab and free (unbound) anti-golimumab antibodies in human serum. |
| Detailed Description | The golimumab concentration is determined on a solid-phase capture EIA that makes use of an golimumab-specific human monoclonal antibody. The concentration of anti-golimumab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of golimumab and the concentration of anti-golimumab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a collection kit to customers. To order a kit, visit Test Ordering - Instructions. Please, follow instructions inside the kit.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of golimumab trough levels is important when interpreting the concentration of anti-golimumab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before golimumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of golimumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before golimumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of golimumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If not be processed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C). |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
For Research Use Only (RUO). Not for use in diagnostic procedures.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Etanercept (ETN)
TDMonitor Etanercept (ETN)
| Test Code | 9008926 |
| Test Name | TDMonitor Etanercept (ETN) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of etanercept and free (unbound) anti-etanercept antibodies in human serum. |
| Detailed Description | The etanercept concentration is determined on a solid-phase capture EIA that makes use of an etanercept-specific human monoclonal antibody. The concentration of anti-etanercept antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of etanercept and the concentration of anti-etanercept antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a Collection Kit for Customers. Please follow instructions inside the kit. To order your kit, please visit Test Ordering - Instructions
Grifols also accepts direct ordering from Labs, Physician Offices or others. Please follows instructions bellow for successful delivery
Grifols also accepts direct ordering from Labs, Physician Offices or others. Please follows instructions bellow for successful delivery
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of etanercept trough levels is important when interpreting the concentration of anti-etanercept antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before etanercept treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of etanercept, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before etanercept treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of etanercept, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If not be processed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C) |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
For Research Use Only (RUO). Not for use in diagnostic procedures.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Rituximab (RTX)
TDMonitor Rituximab (RTX)
| Test Code | 9008927 |
| Test Name | TDMonitor Rituximab (RTX) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of rituximab and free (unbound) anti-rituximab antibodies in human serum. |
| Detailed Description | The rituximab concentration is determined on a solid-phase capture EIA that makes use of an rituximab-specific human monoclonal antibody. The concentration of anti-rituximab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of rituximab and the concentration of anti-rituximab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a collection kit to customers. To order a kit, visit Test Ordering - Instructions. Please, follow instructions inside the kit.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of rituximab trough levels is important when interpreting the concentration of anti-rituximab antibodies, i.e. when evaluating interference of the drug with the antibody test.
It is recommended to collect samples immediately before rituximab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of rituximab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
It is recommended to collect samples immediately before rituximab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of rituximab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If not be processed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C) |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
For Research Use Only (RUO). Not for use in diagnostic procedures.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
TDMonitor Tocilizumab (TCZ)
TDMonitor Tocilizumab (TCZ)
| Test Code | 9008928 |
| Test Name | TDMonitor Tocilizumab (TCZ) |
| Test Method | Enzyme-linked immunosorbent assay (EIA) |
| Brief Description | Immunoassay for the quantitative detection of Tocilizumab and free (unbound) anti-Tocilizumab antibodies in human serum. |
| Detailed Description | The Tocilizumab concentration is determined on a solid-phase capture EIA that makes use of an Tocilizumab-specific human monoclonal antibody. The concentration of anti-Tocilizumab antibodies is determined on a solid-phase bridging EIA. |
| Clinical Information | Trough levels of Tocilizumab and the concentration of anti-Tocilizumab antibodies, together with clinical parameters such as disease activity, can be valuable information for patient management. |
Grifols offers a collection kit to customers. To order a kit, visit Test Ordering - Instructions. Please, follow instructions inside the kit.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
Grifols accepts direct ordering from labs and physician offices. Please, follow instructions bellow for a successful receipt of samples at the lab.
| Specimen | Volume/Amount | Container |
|---|---|---|
| Serum | 2 mL | Serum Separator Tube (SST) |
Determination of Tocilizumab trough levels is important when interpreting the concentration of anti-Tocilizumab antibodies, i.e. when evaluating interference of the drug with the antibody test.>br> It is recommended to collect samples immediately before Tocilizumab treatment, when the drug is at trough levels.
If the patient is continuously treated with courses of Tocilizumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
If the patient is continuously treated with courses of Tocilizumab, it is also recommended that the sampling sequence be maintained in order to enable appropriate comparison of results.
| Specimen | Conditions |
|---|---|
| Serum | Sample can be stored at room temperature (20-25°C) for up to 48 hours, or refrigerated (2-8°C) for up to 7 days. If not be processed within 5 days, freeze it at –20°C or lower. Avoid repetitive freeze-thaw cycles. |
| Specimen | Conditions |
|---|---|
| Serum | Can be transported at room temperature (20-25°C) for up to 48 hours, otherwise refrigerated (2-8°C) |
| Time Around Time | 3 to 5 business days from receipt of sample |
| Test Price ($) | Please contact your Grifols sales representative or Grifols lab customer support at dxscmcustomer.service@grifols.com |
For Research Use Only (RUO). Not for use in diagnostic procedures.
To review, please visit Therapeutic Drug Monitoring > Clinical Value
This information is intended for physicians and healthcare professionals only.
Product registration and availability vary by country. For more information on product availability, please contact us here.